Latest Breaking News On - Gamma vaccines pty ltd - Page 4 : comparemela.com
Global $9 5 Billion Influenza Vaccines Market to 2027
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Influenza Vaccine Market Swot Analysis by key players Sinovac Biotech, GlaxoSmithKline (GSK), Gamma Vaccines
sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.
Influenza Vaccine Market Swot Analysis by key players Sinovac Biotech, GlaxoSmithKline (GSK), Gamma Vaccines
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
Influenza Vaccine Market Trends 2020| Segmentation, Outlook, Industry Report to 2027 Trends Market Research added Most up-to-date research on Influenza Vaccine Market to its huge collection of research reports.
Trends Market Research
BriefingWire.com, 5/06/2021 - The global influenza vaccine market was valued at $3.96 billion in 2018, and is projected to reach $6.20 billion by 2026, registering a CAGR of 5.9% from 2019 to 2026.
Influenza, commonly known as flu, is a contagious respiratory infection caused by influenza viruses. Four types of influenza viruses include type A, B, C, and D. The most common types of influenza viruses responsible for seasonal flu each year are type A and B. These viruses enter into the respiratory system of an individual, and are transmitted to other individuals by direct contact or inhalation of virus-laden aerosols. The ideal method to prevent influenza is through vaccination.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The number of people being vaccinated with influenza vaccines worldwide will reach 500 million by the year-end of 2027.
The Report Analyses the Market Based on Countries and Presents the Forecast in Terms of Value and Volume for the Next Six Years.
Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccines, the introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most of the countries.
Long-term Growth Projection:
The global influenza vaccines market size is set to surpass US$ 6.5 Billion by the year-end of 2021